Part 4: 4 Medications That Stop Diabetic Kidney Failure

4 Medications That Stop Diabetic Kidney Failure—Why Most Doctors Miss These Part 4 reveals the life-saving medications that prevent dialysis in diabetic kidney disease—yet many doctors still aren't prescribing them. This 49-year-old patient came to me with kidney function of 24, severe protein spillage, and was getting "1990s care." Today I'll show you the 4 classes of medications backed by landmark trials that stop kidney failure progression and why your doctor needs to know about them. ━━━━━━━━━━━━━━━━━━━━ ⏱️ TIMESTAMPS: 00:00 Patient Success Story: GFR 24 to 36 01:13 The Treatment Gap Killing Kidneys 02:14 Subscribe for Weekly Kidney Protection Tips 02:24 Layer 1: ACE Inhibitors/ARBs (The Foundation) 05:19 Layer 2: SGLT-2 Inhibitors (The Game Changer) 08:19 Layer 3: Finerenone (The New Standard) 11:45 Layer 4: GLP-1 Agonists (Multi-Drug Benefits) 14:45 Layer 5: Supporting Cast (Blood Pressure & Cholesterol) 16:20 Cost Solutions & Patient Assistance 17:08 Red Flags Your Doctor Is Behind 17:40 How to Talk to Your Doctor 18:20 Your Action Plan This Week 18:51 Final Thoughts & Call to Action ━━━━━━━━━━━━━━━━━━━━ 📺 WATCH THE COMPLETE SERIES: Part 1: Nutrition Strategy That Protects Kidneys →    • PART 1: Stop Following Kidney Diets - Here...   Part 2: How Diabetes Damages Kidneys (Cellular Level) →    • Part 2: Diabetes Kidney Damage: 5 Deadly S...   Part 3: Can Kidney Damage Be Reversed? →    • Why Your Doctor Says Kidney Damage Is Irre...   Part 4: Medications That STOP Kidney Failure (You Are Here) →    • Part 4: 4 Medications That Stop Diabetic K...   ━━━━━━━━━━━━━━━━━━━━ 🎯 IN THIS VIDEO: ✓ The 4 medication classes that prevent dialysis in diabetics ✓ Why SGLT2 inhibitors are game-changers for kidney protection ✓ GLP-1 agonists: Not just for weight loss anymore ✓ Finerenone: The breakthrough nonsteroidal MRA ✓ Why many patients are getting "1990s care" in 2025 ✓ Landmark trials: EMPA-KIDNEY, DAPA-CKD, FIDELIO-DKD, FLOW ✓ Questions to ask your doctor TODAY ━━━━━━━━━━━━━━━━━━━━ 📖 RESEARCH CITED: American Diabetes Association (2025) - Standards of Care in Diabetes KDIGO (2024) - Clinical Practice Guideline for Diabetes Management in CKD EMPA-KIDNEY Trial (2023) - Empagliflozin in Chronic Kidney Disease DAPA-CKD Trial (2020) - Dapagliflozin in CKD Patients FIDELIO-DKD Trial (2020) - Finerenone Effect on CKD Outcomes FLOW Trial (2024) - Semaglutide Effects on CKD in Type 2 Diabetes Complete references & show notes exclusively for members →   / seanhashmimd   ━━━━━━━━━━━━━━━━━━━━ 💡 CRITICAL TAKEAWAY: If you have diabetic kidney disease and your doctor hasn't discussed SGLT2 inhibitors, GLP-1 agonists, or finerenone with you, print this video's reference list and bring it to your next appointment. These medications have been proven in landmark trials to reduce kidney failure risk by 30-40%—but many doctors aren't prescribing them yet. ━━━━━━━━━━━━━━━━━━━━ 💎 BECOME A MEMBER — $10/Month →   / seanhashmimd   What You Get: Monthly Live Q&As with Dr. Hashmi Complete Show Notes & Scientific References Downloadable Medication Guide for Diabetic Kidney Disease Exclusive SELF Principle Resources Behind-the-Scenes Access & Priority Topics Private Member Community →   / seanhashmimd   ━━━━━━━━━━━━━━━━━━━━ 🔔 SUBSCRIBE for weekly evidence-based health content: →    / @seanhashmimd   ━━━━━━━━━━━━━━━━━━━━ 💬 Questions for YOU: 1. Are you on any of these 4 medication classes? 2. Has your doctor discussed kidney-protective medications with you? Drop your answers below—I read every comment and use them to guide future videos. ━━━━━━━━━━━━━━━━━━━━ 🌐 CONNECT: Instagram:   / seanhashmimd   Patreon:   / seanhashmimd   Newsletter: https://www.selfprinciple.org/newsletter Website: https://www.selfprinciple.org ━━━━━━━━━━━━━━━━━━━━ ⚕️ MEDICAL DISCLAIMER: Educational content only. Not medical advice, diagnosis, or treatment. Never stop or change medications without consulting your healthcare provider. Always discuss medication changes with your doctor before making any adjustments. Views are Dr. Hashmi's professional opinions and don't represent any employer or institution. Viewing doesn't establish a doctor-patient relationship. #DiabeticKidneyDisease #SGLT2Inhibitors #GLP1Agonist #KidneyHealth #DiabetesMedications #PreventDialysis #EvidenceBasedMedicine #SeanHashmiMD